Ledger.Open graph →
SEC Form D · Amendment · filed December 30, 2015

Perle Bioscience, Inc

Offering
$2.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Other
Location
CHARLESTON, SC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Claresa N. Levetan · Charleston, SCExec · DirectorDonna N. Hill · Charleston, SCDirectorRyan N. Fiorini · Charleston, SCExec · DirectorDouglas N. Carnes · Charleston, SCDirectorJeffrey N. Riley · Charleston, SCDirectorGilbert N. Nathan · Charleston, SCDirectorC. M. Cox · Dallas, TXDirectorRobin Berzin · New York, NYDirectorAydin Babakhani · Katy, TXExec · DirectorOmar Kulbrandstad · Katy, TXExec · DirectorRobert W. Fordi · ANNAPOLIS, MDDirectorScott Bigham · Austin, TXDirectorSteven D. Scheiwe · SEATTLE, WADirectorTagar C. Olson · SEATTLE, WADirectorDiane B. Glossman · SEATTLE, WADirectorMichael L. Willingham · SEATTLE, WAExec · DirectorCharles E. Smith · SEATTLE, WAExec · DirectorMichael J. Renoff · SEATTLE, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗